Skip to content

Study of a Prototype Software to Help Surgical Patients Manage Their Pain Medication

Evaluation of the Feasibility of an Expert Decision Support System for Patients Regarding the Optimization of the Management of Drugs With Conditional Administration in the Surgical Department: Pilot Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05707247
Acronym
MORPHEE 2
Enrollment
37
Registered
2023-01-31
Start date
2023-02-13
Completion date
2023-07-04
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-operative Situation

Keywords

prototype software, patient interface, experimental medical device

Brief summary

The experimental medical device is a prototype software. The device comes in the form of a smartphone with a touch interface. The smartphone used to support the software is a commercial smartphone marked CE. The study aims at assessing the feasibility of the use of this expert, patient- decision support systems. The study hypothesis is that the clinical use of the experimental device is feasible.

Interventions

DEVICEsoftware

The experimental medical device is a prototype software. It is a patient interface. The device comes in the form of a smartphone with a touch screen

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or Female 18 years or older (no upper age limit) * Operated within a surgical department of of the Hautepierre University Hospitals of Strasbourg * Patient understanding and reading French * Subject neurosensorially able of interacting with a tactile electronical interface * Subject able to understand research objectives, risks and provide dated and signed informed consent * Subject covered by a health insurance scheme

Exclusion criteria

* Patient with neuropsychiatric or sensory disorders that may interfere with their use of the visual interface * Unable to provide informed information (subject in emergency, difficulty understanding the subject, etc.) * Pregnant or lactating woman (on declaration) * Patient under safeguard of justice, under guardianship, under curatorship

Design outcomes

Primary

MeasureTime frameDescription
Rate of Agreement Between the Recommendations of the INSAMED Computer Tool and the Recommendations Made by a Healthcare Professional From the Research Team Based on the Best Practice Algorithm.Day 2 post operativeRecommendation pairs were analyzed in this Outcome Measure for the number of recommendation pairs that matched recommendations between the INSAMED Computer Tool and the Healthcare Professional, The recommendations of the INSAMED computer tool will be collected by extracting the history from the digital interface (commercial smartphone) hosting the expert system. The recommendations established by a caregiver from the research team based on a best practice algorithm will be determined: After receiving the device activation message, a caregiver (registered nurse) from the research team will establish a recommendation based on the medical algorithm for treating the symptom, medical prescriptions and the patient's interview without consulting INSAMED. The response provided by the nurse in charge of the patient is not used as the gold standard because, in practice, the responses provided may differ from the medical ideal (e.g. unavailability of staff or non-compliance with the care plan).

Countries

France

Contacts

PRINCIPAL_INVESTIGATOREric NOLL, MD

Hôpitaux Universitaires de Strasbourg

Baseline characteristics

Characteristic
Age, Continuous64 year
Sex: Female, Male
Female
15 Participants
Sex: Female, Male
Male
15 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 0
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 15, 2026